UPDATE 6-AbbVie looks beyond Humira with $63 bln deal for Botox-maker Allergan
June 25, 2019 at 15:05 PM EDT
Drugmaker AbbVie Inc said on Tuesday it would acquire Allergan Plc for about $63 billion, giving AbbVie control over the lucrative wrinkle treatment Botox and buying time to seek new growth before its blockbuster arthritis treatment Humira loses U.S. patent protection.